HEPATITIS B VIRUS E ANTIGEN AND ANTIBODY (HBEAG/ ANTI-HBE) - ANVISA Registration 80345000012

Access comprehensive regulatory information for HEPATITIS B VIRUS E ANTIGEN AND ANTIBODY (HBEAG/ ANTI-HBE) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80345000012 and manufactured by manufacturer not specified. The registration is held by GOYAZES BIOTECNOLOGIA LTDA with validity until Jan 07, 2028.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 2 companies making the same product including BIOMERIEUX SA, LABTEST DIAGNOSTICA S/A, and 3 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.